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Ultrasound has been identified as a possible non-invasive drug delivery 
device that could avoid many of the problems found in traditional therapeutics.  
Studies have shown that ultrasound can deliver molecules into cells; however, 
the applicability of ultrasound has been limited due to uncontrollable cellular 
viability losses after sonication.  In this study, we sought to quantify the 
heterogeneous bioeffects of ultrasound in order to gain more insight into how 
ultrasound affects cells.  We were also concerned with identifying the causes of 
and preventing programmed cell death caused by ultrasound exposure.  In order 
to accomplish these objectives, we used flow cytometry to group cells into 
quantifiable characteristic populations.  This allowed us to identify the relative 
importance of different forms of rapid cell death.  We found that up to 65% of 
cells (at the highest ultrasound pressure studied) can lose viability rapidly and, 
for the first time, quantified them among three distinct populations: (1) cells that 
retain normal size but lose plasma membrane integrity; (2) intact nuclei 
surrounded by plasma membrane remnants; (3) debris resulting from cellular 
lysis.  Our analysis was supported by mechanical sorting of these populations 
and subsequent imaging using confocal microscopy.  We then monitored the 
viable populations for 6 h after ultrasound exposure.  Results indicated that up to 
15% of viable cells (at the highest ultrasound pressure studied) underwent 
apoptosis, which we showed was associated with an influx of intracellular Ca2+; 
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therefore, we developed a method of chelating intracellular Ca2+ after sonication 
in an effort to maintain viability of those cells.  Using this technique, we showed 
for the first time that cells could be saved, and we were able to prevent apoptosis 
by 50%, thereby increasing the overall viability of cells exposed to ultrasound.  
We conclude that ultrasound is a useful method to deliver molecules into cells 
and that appropriate selection of sonication conditions can minimize cell death by 










1.1 Introduction to Intracellular Drug Delivery 
Along with advances in medicine and pharmaceutical technologies, research 
into targeted drug delivery modalities has increased steadily over the last several 
decades.  Patient treatment options are often limited not by the availability of 
drug and biological therapeutics, but by the ability to deliver a drug to a desired 
location within the body while avoiding side-effects caused by drug interaction 
with unintended targets (Langer 1998).  The ultimate target of many therapeutics 
is inside specific cells where a drug can alter cellular biochemistry to achieve a 
desirable action (Ariuens and Simonis 1964).  Unfortunately, most current drug 
delivery routes lack the ability to target a particular site and rely on the natural 
action of the body to deliver drugs to cells.  This results in drugs inadvertently 
reaching other cells and tissues or being destroyed by bodily clearance 
mechanisms.  For example, many chemotherapeutics are successful in treating 
cancerous cells; however, a lack of specificity usually results in a weakened 
immune system and other dangerous side-effects that can be harmful to a patient 
(Love, Leventhal et al. 1989).   
A variety of studies have been done to overcome the delivery problems 
associated with traditional therapeutics.  Electroporation was one of the earliest 
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identified physical methods to disrupt cellular membranes (Tsong 1991).  Using 
this technique, a voltage is applied across cell membranes, resulting in the 
formation of transient nanometer pores through which drugs and small molecules 
can pass (Canatella, Black et al. 2004).  While electroporation shows the ability 
to effectively deliver molecules into cells, it often involves high voltages and 
cannot easily reach many tissues within the body (Weaver 1993).   
The advent of new therapeutics composed of DNA, RNA, and proteins has 
brought even more challenges to the field of drug delivery (Pouton and Seymour 
2001).  Gene gun therapies use particle bombardment to deliver DNA into 
cellular targets but have limitations due to high cost and poor control (Cupp and 
Bloom 2002).  The use of viruses has also been identified as a potential carrier 
and intracellular delivery vehicle for genetic material; however, the infectious and 
immunological nature of viruses has raised many concerns over their accepted 
use for targeted delivery (Cupp and Bloom 2002). 
An ideal drug delivery system would allow the delivery of a large variety of 
therapeutic molecules to a specific target site in a minimally invasive and cost 
effective manner.  The major benefit of a targeted therapeutic system is that 
overall dosage requirements can be lowered by allowing little to no therapeutic 
losses from drug interaction with non-targeted tissues (Langer 1998).  This 
makes treatments safer and more efficient for the patient.  To accomplish this 
task, a delivery system should be predictable and controllable to ensure that the 
intended target cells and tissues are reached.  
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Due to its accepted use as a noninvasive, yet targeted, diagnostic tool, 
ultrasound has been identified as a possible system to achieve this kind of drug 
delivery.  At intensities higher than those used in diagnostics, ultrasonically-
induced cavitation has been shown to reversibly disrupt the plasma membranes 
of cells (Cochran and Prausnitz 2001; Guzman, Nguyen et al. 2001; Ogawa, 
Tachibana et al. 2001; Tang, Wang et al. 2002; Schlicher, Radhakrishna et al. 
2006; Gac, Zwaan et al. 2007)—the main barrier to intracellular drug delivery.  
Studies have shown the ability of ultrasound to deliver small molecules (Keyhani, 
Guzman et al. 2001; Guzman, Nguyen et al. 2002; Ng and Liu 2002), large 
dextrans (Schlicher, Radhakrishna et al. 2006), and DNA (Duvshani-Eshet and 
Machluf 2005; Paliwal and Mitragotri 2006; Zarnitsyn, Kamaev et al. 2007) into 
cells in vitro.  Other studies have also shown that ultrasound can effectively 
target cellular sites in ex vivo tissues (Hallow, Mahajan et al. 2007) and in vivo 
animal models (Bednarski, Lee et al. 1997). 
Ultrasound fulfills the therapeutic requirements of being easily targeted, 
minimally invasive, and cost effective; however, it has not been realized as a 
clinical tool due to a lack of predictability and controllability (Guzman, Nguyen et 
al. 2001).  Studies have indicated that increasing intracellular delivery of 
molecules using ultrasound comes at a cost of lost cellular viability (Miller, Miller 
et al. 1996; Guzman, Nguyen et al. 2001; Keyhani, Guzman et al. 2001; ter Haar 
2007).  Moreover, both the level of intracellular uptake (Guzman, Nguyen et al. 
2001; Keyhani, Guzman et al. 2001; Guzman, Nguyen et al. 2002) and types of 
viability loss (Guzman, Nguyen et al. 2001; Guzman, McNamara et al. 2003) are 
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heterogeneous and difficult to control.  In this study, we will seek to characterize 
and quantify the relative importance of ultrasound-induced bioeffects.  We will 
also discuss methods to control ultrasound-mediated viability loss. 
 
1.2 Objectives 
The objectives of this study are as follows: 
1) Characterize and quantify ultrasound-mediated bioeffects 
2) Identify causality of ultrasound-induced programmed cell death 
3) Prevent programmed cell death using intervention strategies 
 
1.3 Overview of the Thesis 
This chapter provides an introduction to targeted drug delivery in general and 
gives a brief overview of ultrasound-mediated drug delivery.  Chapter 2 
establishes the relevance of the study and provides background on the physical 
characteristics of ultrasound and cavitation, ultrasound-induced bioeffects, and 
important aspects of cellular biochemistry.  The materials and methods used in 
this study are described in chapter 3.  Chapter 4 will give results of quantification 
and characterization of the short-term effects of ultrasound; whereas, chapter 5 
will look at the downstream cellular effects caused by ultrasound as well as 
means to prevent undesired cellular responses.  The two results sections will be 
discussed in chapter 6, followed by concluding remarks given in chapter 7.  










2.1 Motivation of Study 
 As mentioned previously, the plasma membrane is the primary barrier to 
drug delivery into cells and tissues.  The effectiveness of this barrier can be 
found in the structure of the plasma membrane (McNeil and Steinhardt 1997; Ko 
and McCulloch 2000; Vlahakis and Hubmayr 2000; Morris and Homann 2001).  It 
is composed of a bilayer with hydrophobic lipid domains between hydrophilic 
head groups that face the extracellular environment and the intracellular cytosol.  
This bilayer creates a boundary around the cell that severely limits the types of 
molecules that can pass into and out of the cell (McNeil and Steinhardt 1997).  
These limitations have proven to be major problems for new cellular therapeutics 
that are based on the delivery of genetic material or proteins into cells (Pouton 
and Seymour 2001). 
Ultrasound has been identified as a possible means to overcome the barrier 
posed by the plasma membrane.  At high ultrasound pressures, cavitation has 
been shown to reversibly permeabilize plasma membranes, allowing molecules 
to be delivered into cells (Schlicher, Radhakrishna et al. 2006).  Ultrasound is an 
attractive candidate for targeted drug delivery because it is minimally invasive, 
inexpensive, and well-accepted as a clinical diagnostic tool (Ng and Liu 2002).  
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However, it has suffered from a lack of controllability that is characterized by 
large losses of cellular viability.  An increase in ultrasound pressure generally 
leads to more molecules delivered to cells but also causes more cells to lose 
viability (Guzman, Nguyen et al. 2001).  Cells have even been observed to lose 
viability hours after sonication has ended (Ashush, Rozenszajn et al. 2000; 
Vykhodtseva, McDannold et al. 2001; Lagneaux, de Meulenaer et al. 2002; 
Honda, Kondo et al. 2004; Feril, Kondo et al. 2005). 
In this study we seek to characterize and quantify the various bioeffects 
caused by ultrasound.  We would then like to look at the key factors in cellular 
viability loss that occurs hours after ultrasound exposure and offer methods to 
prevent this type of cell death.  First, however, we will give some background on 
both the physical aspects of ultrasound and the biological response of the cells. 
2.2 Properties of Ultrasound 
 Ultrasound is defined as any frequency of sound greater than 20 kHz, the 
maximum sound frequency that humans can hear (Leighton 2007).  Higher 
ultrasound frequencies provide a smaller focus, and thus, give better targeting 
and finer resolution.  Therefore, ultrasound frequencies for diagnostic procedures 
range from 1 – 30 MHz; whereas, therapeutic procedures tend to use lower 
ultrasonic frequencies ranging from 21 kHz – 5 MHz (Postema and Gilja 2007).  
For this study, an ultrasound frequency of 24 kHz was used.  Lower frequencies 
require less energy to induce cavitation (Leighton 2007), the driving force behind 
ultrasound-mediated drug delivery. 
 
 7 
 In the context of ultrasound, cavitation is defined as the rapid formation 
and oscillation of microbubbles.  At a threshold peak pressure based on the 
ultrasound frequency, microbubbles are formed when dissolved gases nucleate 
in a liquid medium to form gas bubbles surrounded by liquid (Leighton 2007).  An 
increase in ultrasound energy has been shown to cause an increase in the 
number of microbubbles formed, as measure by cavitation (Cochran and 
Prausnitz 2001).  For higher frequencies, the pressure required for microbubble 
nucleation is high; therefore, contrast agents, gas bubbles encapsulated by a 
solid shell, are often used to provide nucleation sites (Dalecki, Raeman et al. 
1997; Kamaev, Hutcheson et al. 2004). The oscillation of microbubbles can 
either be stable, where the bubbles oscillate with the characteristic harmonics 
and subharmonics of the ultrasound wave, or inertial, where the bubbles reach 
critical radii during nonlinear oscillations and then collapse violently (Lauterborn 
and Ohl 1997).  The intense shear energy released from inertial cavitation is 
believed to cause ultrasound-induced bioeffects (Miller, Miller et al. 1996; 
Cochran and Prausnitz 2001). 
 Important Terms 
 Frequency:  the number of cycles in a given period of time 
 Pulse length:  time of one pulse of acoustic energy 
 Duty cycle:  the percentage of time that the transducer produces 
acoustic waves during the total time of ultrasound exposure 




 Ultrasound pressure:  the peak pressure of the acoustic waves 
 Acoustic energy:  a function of the square of the ultrasound 
pressure multiplied by the exposure time 
 Cavitation:  the formation and subsequent oscillation of 
microbubbles 
2.3 Ultrasound-Induced Bioeffects 
 Ultrasound has great potential as a clinical therapeutic tool; however, its 
use has been hampered by the lack of predictability and controllability resulting 
from heterogeneity of ultrasonically-induced bioeffects (Barnett, ter Haar et al. 
1994; Guzman, Nguyen et al. 2001; Dalecki 2004).  Previous studies have 
identified a myriad of cellular bioeffects resulting from sonication.  Our lab 
(Guzman, Nguyen et al. 2002) has previously shown that small macromolecules 
can be loaded into cells at equilibrium levels; the amount of loading strongly 
depends on the applied ultrasound conditions.  Others have shown that larger 
molecules, such as high molecular weight dextrans, can be delivered into cells 
with the amount of delivery dependent upon the size of the molecule (Schlicher, 
Radhakrishna et al. 2006).  Many researchers have built upon this foundation to 
use ultrasound to deliver chemotherapeutics and other drugs to cells and tissues 
in vitro (Husseini, El-Fayoumi et al. 2000; Marin, Sun et al. 2002; Rosenthal, 
Sostaric et al. 2004; Zarnitsyn, Kamaev et al. 2007). 
 With the advent of protein and gene therapies, ultrasound has received a 
significant amount of attention as a potential delivery device (Duvshani-Eshet, 
Baruch et al. 2006; Paliwal and Mitragotri 2006; Campbell and Prausnitz 2007; 
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Zarnitsyn, Kamaev et al. 2007).  Studies have shown that the plasma membrane 
breaks caused by ultrasound are large enough to deliver DNA plasmids into 
cellular cytosol (Mehier-Humbert, Bettinger et al. 2005; Duvshani-Eshet, Baruch 
et al. 2006) and that ultrasound can facilitate transfection in treated cells (Ogawa, 
Kagiya et al. 2004).  Similar studies have shown that ultrasound can also deliver 
proteins and RNA into cells (Kinoshita and Hynynen 2005).  The delivery of these 
macromolecules indicates that ultrasound can create large plasma membrane 
disruptions that can be repaired by cells.  This wound-mediated delivery 
mechanism was supported by experiments performed by Schlicher et. al. 
(Schlicher, Radhakrishna et al. 2006) in which cellular endocytosis was blocked 
but ultrasound-induced intracellular delivery was still observed.  Also, when 
cellular repair pathways were disrupted, cells were not able to recover from 
ultrasound exposure.  Furthermore, microscopy analyses revealed that plasma 
membrane disruptions that lead to uptake of extracellular molecules could be up 
to microns in diameter; however, many cells are unable to recover from these 
disruptions. 
At high acoustic energies, where molecular loading is the highest, cell 
viability drops dramatically (Cochran and Prausnitz 2001; Guzman, Nguyen et al. 
2001; Keyhani, Guzman et al. 2001).  The loss of cell viability observed within 30 
min post-sonication has been attributed to cell lysis (Carstensen, Kelly et al. 
1993; Miller and Quddus 2001; Feril, Kondo et al. 2004) and uncontrolled death 
modes from irreparable wounds to the plasma membrane (Schlicher, Hutcheson 
et al. 2007).  These modes of cell death have been correlated to increased 
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inertial cavitation as monitored by acoustic spectra recordings (Cochran and 
Prausnitz 2001) and contrast agent destruction (Kamaev, Hutcheson et al. 2004).  
The inherent heterogeneity of ultrasound that results in both rapid cell death from 
irreparable plasma membrane wounds and recoverable wounds that lead to 
intracellular uptake has been hypothesized to be a function of cellular distance 
from the site of microbubble collapse (Guzman, McNamara et al. 2003; 
Sundaram, Mellein et al. 2003).  Cells closest to the inertial cavitation event are 
completely lysed; whereas, at some distance away from the implosion, cells are 
not affected. 
 Recent studies have shown that ultrasound treatment can also cause cells 
to undergo a controlled type of cell death, apoptosis, hours after sonication 
(Ashush, Rozenszajn et al. 2000; Vykhodtseva, McDannold et al. 2001; 
Lagneaux, de Meulenaer et al. 2002; Honda, Kondo et al. 2004; Feril, Kondo et 
al. 2005).  Honda, et al. (Honda, Kondo et al. 2004) attributed ultrasound-induced 
apoptosis in lymphoma cells to an increase in cytosolic Ca2+.  This was 
hypothesized to be caused by a large influx of external Ca2+ ions across the 
plasma membrane; however, attempts to save apoptotic cells by chelating 
intracellular Ca2+ resulted in an increase in uncontrolled, necrotic cell death.  
Others have suggested that reactive oxygen species (ROS) that are formed by 
cavitation could also play a role in long-term cell death (Lagneaux, de Meulenaer 
et al. 2002), but follow-up studies have shown that these ROS are very short-
lived (Honda, Zhao et al. 2002; Feril, Kondo et al. 2005) and that treatments with 
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antioxidants fail to inhibit ultrasound-mediated apoptosis (Honda, Kondo et al. 
2004). 
All of the ultrasound-mediated bioeffects listed above (i.e. uptake, rapid 
viability loss, and delayed viability loss) can be broadly grouped into four 
categories:  (1) cells that appear largely unaffected, (2) cells reversibly 
permeabilized, as evidenced by intracellular uptake of molecules, and that 
remain viable, (3) cells rendered nonviable during sonication, as shown by an 
irreversible loss of the plasma membrane barrier or lysis of the cell into debris 
and (4) cells that appear to be viable shortly after sonication, but later undergo 
apoptosis and die.  Applications of ultrasound often seek to maximize the second 
population, in order to achieve intracellular drug or gene delivery, and minimize 
the third and fourth populations, since cell death is generally undesirable. 
2.4 Cellular Wounding and Repair 
 Since ultrasound delivers molecules into cells by disrupting plasma 
membranes, it is important to understand how cells respond to membrane 
wounds.  As discussed above, the plasma membrane carefully regulates the 
movement of molecules into and out of a cell.  When this barrier is disrupted, 
molecules move freely across the plasma membrane to establish a concentration 
equilibrium between the intracellular and extracellular environments.  This 
transport allows ultrasound to deliver molecules into cells; however, the lost 
membrane integrity and loss of normal intracellular ion concentrations can be 
detrimental to the cell (Nicotera, Bellomo et al. 1990; Trump and Berezesky 
1995).  To maintain normal cellular functions, the cell must act quickly to repair 
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disruptions.  This repair process can be complex and energy intensive (McNeil 
and Steinhardt 1997; McNeil, Vogel et al. 2000). 
Cells in normal homeostasis maintain a lower concentration of intracellular 
Ca2+ ions than that of the external cellular environment (Trump and Berezesky 
1992; Berridge, Bootman et al. 1998; Nguyen, Bittner et al. 2005).  When the 
ultrasonically-induced cavitation disrupts plasma membranes of cells, the natural 
concentration gradient causes extracellular Ca2+ ions to rush into cells.  This ion 
movement is necessary in wounded cells because Ca2+ is an initiator and 
messenger in biochemical plasma membrane wound repair pathways 
(Zamansky, Nguyen et al. 1991; Rettig and Neher 2002; McNeil, Miyake et al. 
2003; Meldolesi 2003; McNeil and Kirchhausen 2005).  At a sufficiently high 
concentration, Ca2+ ion binding to cytosolic proteins triggers a biochemical 
cascade that results in the recruitment of lipid repair vesicles to the site of plasma 
membrane wounding (Terasaki, Miyake et al. 1997; McNeil and Kirchhausen 
2005).  These vesicles can then fuse to create a patch to seal the plasma 
membrane disruption.  However, at cytosolic concentrations higher than 
physiologic levels, Ca2+ can also initiate programmed cell death pathways 
(Trump and Berezesky 1992; Nicotera and Orrenius 1998; Burek, Burek et al. 
2003; Orrenius, Zhivotovsky et al. 2003). 
2.5 Cellular Death 
 For the purposes of this study, we will discuss the two most common 
forms of cell death, necrosis and apoptosis.  Uncontrolled, or necrotic, cell death 
is commonly defined as an accidental form of cell death resulting from a 
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disruption of normal cellular functions (Trump, Berezesky et al. 1997; Tsujimoto 
1997).  As used in this context, this mode of cell death can broadly encompass 
cellular lysis and more controlled forms of necrosis (Kroemer, Dallaporta et al. 
1998; Kitanaka and Kuchino 1999; Proskuryakov, Gabai et al. 2002).  The most 
important aspect of cellular necrosis is that the death was not a result of an 
active cellular process, but rather a consequence of a traumatic cellular event 
that resulted in the loss of plasma membrane integrity.  This usually results in 
cytosolic contents spilling into the extracellular environment, which leads to large 
inflammatory responses in the body (Edinger and Thompson 2004). 
 On the other hand, apoptosis, or programmed cell death, is a controlled 
form of cell death that occurs in many normal physiological situations (Bohm and 
Schild 2003).  Many apoptotic pathways have been elucidated, and the cascades 
of enzymes that lead to cell death can be complex (Tsujimoto 1997; Fadeel, 
Zhivotovsky et al. 1999; Bohm and Schild 2003).  During the progression of 
apoptosis the cell membrane remains mainly intact while the nuclear envelope is 
broken and the DNA of the cell is degraded.  The cell then forms small apoptotic 
bodies that consist of a plasma membrane bilayer surrounding damaged 
organelles and DNA fragments (Bohm and Schild 2003).  In the body, these 
bodies are engulfed by macrophages, thus limiting the inflammatory response 
associated with necrosis. 
2.6 Relevance of Work 
 The goal of this study was first to quantify the fraction of cells in each of 
these populations shortly after sonication and as a function of time for up to 6 h 
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after sonication.  In this way, we sought to determine which cells from among the 
initial populations ultimately become the apoptotic cells described in previous 
studies.  Based on this information, our second goal was to determine why those 
cells became apoptotic and to develop a strategy to reverse the effect and keep 
those cells alive.  We must also identify time frames within which intervention 
strategies can be implemented.  If successful, this strategy could facilitate drug 
and gene deliveries using ultrasound by keeping more cells viable.  Finally, we 










3.1 Cell culture 
DU 145 prostate-cancer cells (American Type Culture Collection, 
Manassas, VA) were grown to 80 – 90% confluence on T-150 flasks (BD Falcon, 
Franklin Lakes, NJ) in cellular growth media (RPMI-1640, Cellgro, Herndon, VA) 
that was supplemented with 10% fetal bovine serum (Atlanta Biologicals, Atlanta, 
GA) at 37ºC, 5% CO2, and 90% relative humidity.  The cells were harvested from 
the flasks by trypsinization using previously described protocols (Guzman, 
Nguyen et al. 2001). 
 
3.2 Ultrasound apparatus   
The ultrasound apparatus consisted of a cylindrical piezoelectric 
transducer (Channel Industries, Santa Barbara, CA) sealed between two PVC 
pipes (5.1 cm inner diameter), as described previously (Cochran and Prausnitz 
2001).  This chamber was filled with deionized water that was degassed for at 
least 2 h in a bell jar (Nalgene, Rochester, NY) using a vacuum pump (KNF 
Neuberger, Trenton, NJ) to reduce cavitation in the water bath surrounding the 
cellular samples.     
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Ultrasound was generated at 24 kHz by a function generator (DS354 SRI, 
Stanford Research Systems, Sunnyvale, CA).  The pulsed signal was sent to an 
amplifier (Macro-Tech 2410, Crown Audio, Elkhart, IN) that controlled the 
transducer via a matching transformer (MT-56R, Krohn-Hite, Avon, MA).  Using 
this system, the frequency, duty cycle, incident pressure, and pulse length were 
set.  The exposure time was controlled manually.  The peak ultrasound pressure 
was found using a calibrated hydrophone (Reson, Goleta, California), which gave 
a relationship of P[atm] = 0.0089V, where V is the voltage applied to the 
transducer.  Samples were exposed at room temperature to 20 acoustic pulses 
at a duty cycle of 10% at 24 kHz.  Each pulse applied ultrasound at a peak 
pressure of either 3.6 atm or 5.3 atm for a 0.1 s pulse length.  Sham exposure 
samples (non-sonicated controls) samples were prepared identically to the 
sonicated samples, but no ultrasound was applied (Guzman, Nguyen et al. 
2001).  An image of the overall ultrasound setup is shown in Figure 1a.  A close-




Figure 1.  Ultrasound system used in this study.  (a) A ultrasound wave of 24 
kHz is produced by a function generator, amplified, and sent to the transducer via 
a matching transformer.  (b) The transducer is set between two pvc pipes, 
creating a water-tight bath. 
3.3 Ultrasound exposure 
Following established protocols (Cochran and Prausnitz 2001), well-mixed 
cell suspensions at a concentration of 106 cells/ml in growth media were 
introduced into 1.2 ml sample chambers (No. 241 SEDI-PET SAMCO, San 
Fernando, CA transfer pipets using a 22-gauge needle and 3-ml syringe (Becton-
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Dickinson, Franklin Lakes, NJ).  After the chamber was filled, a stainless steel 
rod (1.6 mm diameter) was inserted into the pipet stem to seal the chamber and 
provide a means to suspend the chamber in the water bath.  Sample chambers 
were then positioned in the exposure chamber water bath by fixing the end of the 
suspending rod into the chamber cover at a location that positioned the sample 
chamber in the axial and radial center of the transducer (Cochran and Prausnitz 
2001). 
 
3.4 Quantification of Intracellular Uptake 
To study uptake, cells were sonicated in RPMI-1640 (with serum) in the 
presence of either 10 µM calcein (Invitrogen, Carlsbad, CA), a plasma membrane 
impermeant green-fluorescent marker or 10 µM sulforhodamine 101 (Invitrogen), 
a plasma membrane impermeant red-fluorescent marker.  After exposure, 
samples were allowed to recover from the effects of sonication for 10 min at 
room temperature and then spun down at room temperature for 6 min at 1000 x g 
to remove excess label from the extracellular medium, followed by washing at 
least twice in phosphate-buffered saline (PBS, Cellgro) and then assayed via 
flow cytometry, as described below.  To determine the amount of intracellular 
calcein uptake in terms of molecules per cell, FITC-calibration beads were used 




3.5 Quantification of Cellular Viability 
 Propidium iodide (PI) (Invitrogen Corp., Carlsbad, CA) exclusion indicates 
an intact cellular membrane and is often used to test for cellular viability.  When a 
cellular membrane has been compromised, PI can enter the cell and bind to the 
cellular DNA.  This binding is detected by the red fluorescence emitted by PI.  To 
determine cellular viability, 7.5 µM PI was added to cell samples at least 5 min 
prior to assaying via flow cytometry.  PI exhibits fluorescence only when bound to 
cellular DNA; therefore, excess PI did not need to be washed from the 
extracellular media. 
 Many cells are lysed by sonication, and thus undetected as whole cells by 
the flow cytometer; therefore, the gated total cells of all sonicated samples were 
normalized to the gated total cells in the control, sham-exposure samples.  The 
control samples were assumed to have no cellular debris.  This assumption 
ensures that all of the quantified cellular lysis resulted from the actual sonication.  
The quantification of debris was done by recording the amount of time required to 
collect 30000 cells in each sample.  Since the cells lost due to lysis resulted in a 
longer required collection time for sonicated samples (i.e. the sonicated samples 
have a lower cell concentration), the amount of lost cells was calculated as the 
balance of cells that would be required for the sonicated samples to have the 
same flow cytometry collection time as the control samples. 
 
3.6 Determination of Intracellular Ca2+ 
 Fluo-4 AM (Invitrogen Corp., Carlsbad, CA) fluoresces upon binding to 
Ca2+ in live cells.  By measuring the intensity of the fluo-4 fluorescence using flow 
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cytometry, cells with increased intracellular Ca2+ can be identified.  For cellular 
loading, fluo-4 AM was dissolved in dimethyl sulfoxide (Sigma-Aldrich, St. Louis, 
MO) at a concentration of 5 mM and added to cellular samples following 
ultrasound exposure and a post-sonication incubation time specified in the 
results at a final concentration of 5 µM.  To assay intracellular Ca2+ levels, 
samples were incubated in the presence of fluo-4 AM at room temperature for 30 
min, washed once in PBS, and then assayed via flow cytometry.   
 
3.7 Annexin V Apoptosis Protocol 
 One of the first identifiable events in the cascade of apoptosis is the 
translocation of phosphatidyl serine to the outer leaflet of the plasma membrane 
in intact cells.  In the body, this translocation signals the recruitment of 
macrophages to remove cellular remnants post-apoptosis.  Fluorescently-
conjugated annexin V (Invitrogen Corp., Carlsbad, CA) molecules bind to 
phosphatidyl serine, allowing early apoptotic cells to be identified using flow 
cytometry.  In the early stages of apoptosis, the plasma membrane of the cell 
remains intact; therefore, early apoptotic cells are differentiated from necrotic 
cells by PI exclusion, similar to the method described for the quantification of 
cellular populations.  Late stage apoptosis, or secondary necrotic cells, cannot be 
identified in this manner.  However, they are usually smaller and lose DNA due to 
the formation of apoptotic bodies.  At the time-points for this study, these 




After sonication, cells were incubated for (i) 4 to 24 h at 37 oC or (ii) up to 
2 h at room temperature.  The cells were then suspended in annexin-binding 
buffer (prepared using standard manufacturer protocols) and incubated with 5 µl 
FITC-conjugated annexin V stock solution (Invitrogen) per 100 µl cell suspension.  
Each sample was analyzed via flow cytometry after 15 min of incubation at room 
temperature. 
 
3.8 Ca2+ Chelation via BAPTA AM 
 BAPTA, AM (Sigma-Aldrich, St. Louis, MO) is often used as a Ca2+ 
chelator in live cells.  BAPTA is similar in structure to and function of EGTA, but 
is less sensitive to changes in pH.  By adding an acetoxylmethyl (AM) ester 
group, the chelating action of BAPTA is inhibited until the molecule is cleaved by 
intracellular esterases.  These factors make BAPTA, AM suitable for intracellular 
Ca2+ chelation.  For chelation, a stock solution BAPTA, AM in dimethyl sulfoxide 
was added to appropriate cellular suspensions 1 min after sonication at a final 
concentration of 130 µM.  Cells were incubated with BAPTA AM at room 
temperature for 30 min and then centrifuged to remove extracellular dimethyl 
sulfoxide.  Samples were then prepared according to protocol for the specified 
assay. 
 
3.9 Flow Cytometric Analysis 
Samples were run on a BD-LSR flow cytometer using FACS DiVa 
software (BD Biosciences, Franklin Lakes, NJ) based on previously established 
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methods (Guzman, Nguyen et al. 2001).  Relative cellular size was obtained 
through measurement of the light scattering properties of the cells as detected by 
forward scatter (FSC) measurements.  The fluorescence of green marker 
compounds (including calcein and Fluo-4 AM) was measured with a 488-nm 
argon laser excitation and a 530/30 bandpass filter for emission.  Red-fluorescent 
propidium iodide was also excited at 488 nm and measured using a 675/20 nm 
bandpass filter for emission.  For each sample, 30000 events were collected from 
a gated region known from previous work (Canatella, Karr et al. 2001) to contain 
DU 145 cells.  Data were analyzed using FCS Express (De Novo Software, 
Thornhill, Ontario) flow cytometry analysis software.  Table I shows a breakdown 
of how the various assay markers were used to identify cellular characteristics. 
 
Table I.  Cellular Categorization with Various Assays 
 Calcein PI Annexin FSC 
Viable, 
No Uptake 
- - - Normal 
Viable, 
Uptake 
+ - - Normal 
Necrotic - + + Smaller 
Early 
Apoptotic 











 Previous studies have quantified how cells shift from viable cell 
populations before sonication to a distribution of uptake and viable cell 
populations immediately after sonication (Guzman, Nguyen et al. 2001).  
However, limited attention has been given to the quantitative distribution among 
the types of viability loss after ultrasound exposure.  This study offers a new 
analysis for characterizing cells after sonication.  We believe that it will give 
valuable insight into the relative importance of cellular effects. 
4.2 Quantification of Viability in Cellular Populations 
The first goal of this study was to quantify the fraction of cells among 
characteristic populations created shortly after sonication.  These populations 
can be distinguished in part by measured cellular forward scatter on the flow 
cytometer, which is a measure of relative cell size, and propidium iodide (PI) 
fluorescence, which is a measure of cell viability determined by plasma 
membrane exclusion of the dye.  These measurements were made 15 to 30 min 
after sonication ended, which is longer than the transient state of membrane 
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permeability associated with ultrasound (Schlicher, Radhakrishna et al. 2006).  
Thus, propidium iodide labeling is interpreted as identifying nonviable cells. 
 As shown in Figure 2a, in the absence of ultrasound, most cells exhibited 
strong forward scatter and weak propidium iodide fluorescence.  This is 
consistent with a population of intact, viable cells.  We have labeled this group of 
cells as populations 1 and 2 because we do not yet have information on 
intracellular uptake.  Population 1 cells are intact and viable without uptake and 
Population 2 cells are intact and viable with uptake.  In Figure 2a, 98% of cells 
fell in this category of intact viable cells. 
 After cells were exposed to sonication, many additional cellular outcomes 
are evident, as shown in Figure 2b.  Some cells (40%) remained in the region of 
strong forward scatter and weak propidium iodide fluorescence (i.e. intact, viable 
cells in Populations 1 and 2) after sonication at 3.6 atm.  At 5.3 atm of ultrasound 
pressure, only 28% of cells remained in this population.  Other cells exhibited 
strong PI fluorescence, with either no change in forward scatter (1% at 3.6 atm 
exposure and 0.5% at 5.3 atm exposure) termed Population 3A or a decrease in 
forward scatter (45% at 3.6 atm exposure and 58% at 5.3 atm exposure) termed 
Population 3B.  In previous analysis coupling flow cytometry with microscopy 
(Schlicher, Hutcheson et al. 2007), these cells have been identified as intact, 
non-viable cells (Population 3A) and wound-derived perikarya, which are cells 
that have lost cytosol, but retain an intact nucleus in a smaller cell (Population 
3B).  Other cells have very weak forward scatter and moderate (Population 3C) 
or weak (Population 3D) PI fluorescence.  We previously identified these as 
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debris from cells lysed during sonication containing nuclear fragments with DNA 
(Population 3C) or without DNA (Population 3D) (Schlicher, Hutcheson et al. 
2007).  Since these populations do not correspond to whole cells, they cannot be 
independently quantified.  Therefore, we calculated these cells as the balance of 
cells no longer counted after sonication.  At an ultrasound pressure of 3.6 atm, 
only 2% of cells fall into this category, but when the pressure is increased to 5.3 




Figure 2.  Cellular populations before and after ultrasound exposure.  (a) A flow 
cytometry plot of PI versus cell size for control samples shows cells mainly 
grouped into Populations 1 and 2.  (b) After sonication, cells shift into non-viable 
populations (Population 3).  (c) A histogram of calcein uptake shows background 
fluorescence in a control sample.  (d) Sonicated cells show increased 
intracellular uptake (Population 2). 
4.3 Quantification of Uptake in Viable Cellular Populations 
Our analysis so far has distinguished between viable (Populations 1 and 
2) and various types of nonviable (Populations 3A-D) cells.  Among the viable 
cells, we next wanted to distinguish between those without uptake (Population 1) 
and with uptake (Population 2) of calcein, a green fluorescent tracer molecule 
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that is unable to enter intact cells.  In contrast to PI, which was added to cells 
well after sonication and thereby labeled irreversibly permeabilized (i.e. 
nonviable) cells, calcein was added prior to sonication, and remained present 
during sonication.  In this way, calcein uptake identifies cells reversibly 
permeabilized by ultrasound, because cells permitted calcein entry initially and 
then retained calcein intracellularly during post-sonication washing, which 
indicates a return of plasma membrane integrity. 
 In Figures 2c-d, we show the subset of cells analyzed in Figures 1a-b that 
were intact and viable (Populations 1and 2) as a function of their green 
fluorescence corresponding to uptake of calcein.  As shown in Figure 1c, most 
cells in the control sample (92% of intact cells) show only background levels of 
green fluorescence, consistent with normal, non-sonicated cells.  The small 
amount showing signs of intracellular uptake (8% of intact cells) is probably due 
to calcein sticking to the cellular membrane and/or from endocytosis.  In contrast, 
sonicated cells show a range of calcein uptake levels with a large group of intact, 
viable cells having background fluorescence similar to controls, another group 
having high fluorescence (high uptake), and a third group having low 
fluorescence (low uptake) in between.  At 3.6 atm of ultrasound pressure, 10% of 
intact cells show low uptake and 10% show high uptake, and at 5.3 atm of 
ultrasound pressure, 15% of intact cells show low uptake and 24% show high 
uptake.  This analysis allows us to distinguish between viable cells with 
background fluorescence (Population 1) and viable cells with elevated 
fluorescence indicating intracellular uptake (Population 2).  The percentages of 
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all of the populations described above are compiled into the bar graph shown in 
Figure 3a. 
 
Figure 3.  Cells are distributed across multiple populations after sonication.  (a) A 
stacked bar graph shows a break down of the quantifiable populations.  (b) An 
image of a cell sorted from viable populations (Populations 1 and 2) is shown to 
be unaffected by sonication.  (c) A cell sorted from viable populations 
(Populations 1 and 2) shows intracellular calcein uptake (Population 2).  (d) A cell 
sorted from Population 3 retains normal cellular size but has lost the ability to 
exclude PI (Population 3A).  (e) A cell sorted from population 3 has an intact 
nucleus with plasma membrane remnants (Population 3B).  (f) Cellular debris 
were collected by sorting all other populations. 
4.4 Mechanical Sorting of Populations 
To correlate our flow analysis with microscopy observations, we separated 
the cells into physical populations using a cell sorter based upon the gated 
populations of the analysis.  Due to limitations of the instrument, we were able to 
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sort the samples using only two separate gates: events from Populations 1 and 2 
in one gate and events from Populations 3A and 3B in the other.  The debris 
populations (Populations 3C and 3D) were sorted by collecting all events not in 
these two gated regions.  We then imaged the outputs from the sorting by 
confocal microscopy immediately after the samples were collected. 
Representative images from sorting are shown in Figures 3b-f.  Figures 3b 
and 3c show cells sorted from Populations 1 and 2.  The cell in Figure 3b shows 
no obvious plasma membrane disruptions and no calcein uptake; therefore, this 
cell is consistent with our interpretation of Population 1 cells as unaffected.  The 
cell in Figure 3c is also PI-negative, indicating an intact plasma membrane; 
however, this cell exhibits uptake of green-fluorescent calcein, signifying a 
repaired, transient membrane disruption and is consistent with Population 2 cell 
classification in our flow cytometric analysis.  
The cells shown in Figures 3 d-f were sorted from Populations 3A, 3B and 
3C.  The cell shown in Figure 3d is similar in size to the cells from Population 1 
but exhibits red PI fluorescence.  Therefore, this cell would be classified as a 
Population 3A cell in our flow cytometric analysis.  Figure 3e shows an intact 
nucleus that exhibits PI fluorescence and has remnants of disrupted plasma 
membrane as shown by the entrapment of calcein.  These structures are 
representative of the wound-derived perikarya of Population 3B. 
Figure 3f shows cellular debris sorted from Populations 3C and 3D.  
These debris consist of fragmented nuclei, organelles, and plasma membrane 
components; however, intact cells were no longer discernible in this image.  The 
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representative populations obtained by sorting strengthen the validity of our flow 
cytometric analysis and provide a key link between quantifiable cellular 
characteristics and microscopy-observed cellular morphologies.   
4.5 Significance 
 These results demonstrate the relative importance of the various 
ultrasound-induced bioeffects.  Previously, these bioeffects were categorized in 
very general terms as uptake cells or dead cells.  However, we have developed a 
means of measuring viability in a much more detailed manner.  These new 
techniques allow us to understand the connection between the physical 
ultrasound conditions and the biological responses of the cells.  By breaking the 
responses down into populations, we can begin to look at each population 











 Our previous analysis identified the cellular populations created 
immediately after sonication.  A detailed and quantitative study of how cells may 
shift populations over time after sonication is lacking in the literature and 
therefore was the focus of our next analysis.  If ultrasound is to be used for drug 
and gene delivery, it is necessary to understand the ultimate effects of ultrasound 
beyond the immediate consequences.   
Our greatest concern was to track the movement of cells from Populations 
1 and 2 into Population 3.  We did not expect other shifts among populations 
because non-uptake cells (Population 1) were unlikely to become uptake cells 
(Population 2) well after sonication and non-viable cells (Population 3) were 
unlikely to become viable (Populations 1 and 2).  However, cells that initially 
remained viable after sonication (Populations 1 and 2) could later lose viability 
(Population 3) as discussed in previous studies on ultrasound-induced apoptosis 
(Ashush, Rozenszajn et al. 2000; Lagneaux, de Meulenaer et al. 2002; Honda, 
Kondo et al. 2004; Feril, Kondo et al. 2005).  We therefore monitored cells for 6 h 
after sonication, a time point previously identified as a maximum for early stages 
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of apoptosis caused by ultrasound (Feril, Kondo et al. 2004; Honda, Kondo et al. 
2004). 
5.2 Long-term Cell Death By Apoptosis 
 Figure 4 shows a breakdown of the two populations of cells initially 
classified as viable (Populations 1 and 2) after sonication.  These two 
populations are shown as a percentage of intact cells and are distinguished by 
calcein fluorescence, indicating intracellular uptake in Population 2 cells.  After 6 
hours, the percentage of intact cells exhibiting intracellular uptake decreased by 
15% in samples exposed to 5.3 atm of sonication pressure (Figure 3b, ANOVA p 
< 0.05).  Correspondingly, the percentage of intact cells without calcein 
fluorescence increased by 15% in the same sonicated samples (Figure 4a).  
Since the overall percentage of intact cells (Populations 1 and 2) did not change 
over the 6 h period (data not shown), this indicates that a sizeable portion of 
uptake cells lost the ability to retain calcein (i.e. cells have shifted from 
Population 2 to Population 1) hours after sonication.  Although the effect to cells 
in Population 2 appears initially to be reversible, this additional analysis shows 
that some cells have lasting effects that do not manifest themselves until hours 
later.  When apoptotic pathways are initiated, cellular membranes can slowly 
become “leaky” (Darzynkiewicz, Bruno et al. 1992); therefore, intracellular calcein 
can diffuse out of the cells.  We hypothesize that the delayed loss of cells in 
Population 2 is the result of apoptosis, possibly stimulated by the transient loss of 





Figure 4.  A separation of viable cells at three different conditions.  Diamonds 
represent cells not exposed to ultrasound.  Squares represent cells exposed to 
an ultrasound pressure of 3.6 atm.  Triangles represent cells exposed to an 
ultrasound pressure of 5.3 atm.  (a) Population 1 cells in samples exposed to 5.3 
atm show a percentage increase after 6 h post-sonication.  (b)  Correspondingly, 
Population 2 cells in samples exposed to 5.3 atm show a quantifiable percentage 
decrease after 6 h post-sonication. 
 
 To test the hypothesis that DU145 cells die by apoptosis hours after 
ultrasound exposure, we used an annexin V assay as described in Chapter 3.  All 
of the data presented were collected 6 hours post-sonication.  Figures 5a-b show 
 
 34 
the results of annexin V staining for a non-sonicated cell sample (Figure 5a) and 
a cell sample exposed to a sonication pressure of 5.3 atm at 6 hours post-
sonication (Figure 5b).  The quadrants were set based upon background 
fluorescence on non-sonicated samples.  Cells in the lower left quadrant are 
normal viable cells.  The upper right quadrant consists of cells that have lost 
plasma membrane integrity and is almost exclusively (95%) composed of cells 
from Population 3.  Apoptotic cells show increased annexin V fluorescence but 
largely exclude PI and are grouped into the lower right quadrant of Figure 5b.  At 
6 hours after ultrasound exposure, 10% of intact cells for samples exposed to 3.6 
atm of ultrasound pressure and 15% of intact cells for samples exposed to 5.3 
atm of ultrasound pressure exhibit annexin V fluorescence and mostly exclude PI 
(Figure 5b, Lower Right Quadrant).  The small increase in PI fluorescence shown 
by cells in this quadrant is most likely due to the leaky plasma membranes of 
early apoptotic cells.  This observation is consistent with the loss of calcein from 
Population 2 cells as discussed in the previous section.   
These results support the hypothesis that ultrasound induces apoptosis in 
sonicated cells hours after the initial exposure.  A loss of cells from our desired 
population of uptake cells (Population 2) is of concern.  We next sought to 
determine what caused some uptake cells to become apoptotic, with the goal 





Figure 5.  Flow cytometric dot plots connect apoptosis to increased intracellular 
Ca2+.  (a) Most non-sonicated cells are viable (PI-negative) and not undergoing 
apoptosis (annexin-positive).  (b) At 6 h after ultrasound exposure, a sizeable 
number of cells are PI-negative but are in the early stages of apoptosis (annexin-
positive).  (c) Non-sonicated cells have background levels of Ca2+ fluorescence 
and are not undergoing apoptosis at 6 h post-sonication.  (d) Most of the 
apoptotic cells in sonicated samples have higher levels of intracellular Ca2+. 
5.3 Ca2+ in Apoptotic Cells 
The observed apoptosis occurred in samples sonicated in the presence of 
cellular growth medium in the absence of any assay markers.  This technique 
ensures that the apoptosis was not caused by the presence of any assay 
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molecule alien to the cell and indicates that the apoptotic trigger did not originate 
from an influx of molecules and ions in the cellular growth medium.  As 
mentioned previously, the onset of apoptosis after ultrasound exposure has been 
hypothesized to be a function of increased intracellular Ca2+ levels (Honda, 
Kondo et al. 2004).  To determine whether ultrasound exposure resulted in 
increased intracellular Ca2+, we used Fluo-4 AM, a Ca2+ specific fluorescent 
indicator, as described in Chapter 3.  Figure 5c shows the results of this Ca2+ 
assay in a non-sonicated sample, and Figure 5d shows the change in Ca2+ and 
annexin V fluorescence in viable cells after an ultrasound exposure of 5.3 atm.  
All annexin-positive (i.e. apoptotic) cells also show an increase in intracellular 
Ca2+, and all cells with the highest levels of intracellular Ca2+ exhibit annexin V 
fluorescence (Figure 5d, Upper Right Quadrant).  This supports the hypothesis 
that ultrasound-induced apoptosis is associated with, and possibly initiated by, an 
increase in cytosolic Ca2+.  These results also suggest that cells that were initially 
classified as viable, uptake cells (Figure 2, Population 2) could be undergoing 
apoptosis hours after sonication due to a large influx of Ca2+ across the disrupted 
plasma membrane.  When the ultrasonically-induced cavitation disrupts the 
plasma membrane of the cell and thereby permits entry of calcein molecules, the 
natural concentration gradient also causes extracellular Ca2+ ions to rush into the 
cell. 
 This suggests that viable uptake cells (Population 2) can die by apoptosis 
due to an influx of Ca2+ ions.  However, the data indicate that a sizeable portion 
(approximately 20% of intact cells) of uptake cells retain calcein up to 6 hours 
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after sonication.  This could imply that the initiation of apoptosis is sensitive to the 
level of Ca2+ loading.  Based upon studies done on the link between Ca2+ and 
apoptosis, once a threshold concentration is reached, a cell may no longer be 
able to return to normal conditions (Berridge, Bootman et al. 1998; Nicotera and 
Orrenius 1998; Wertz and Dixit 2000; Orrenius, Zhivotovsky et al. 2003; Nguyen, 
Bittner et al. 2005).  Uptake cells that do not reach this Ca2+ threshold may be 
able to recover and retain viability.  We hypothesize that the level of intracellular 
Ca2+ loading is dependent upon the extent of plasma membrane wounding 
caused by ultrasound.   
 In order to relate the influx of Ca2+ to plasma membrane wounding (as 
indicated by calcein uptake), we plotted calcein uptake versus intracellular Ca2+ 
in viable cells.  Figure 6 shows a representative plot of non-sonicated cells 
(Figure 6a) and of cells sonicated at 5.3 atm (Figure 6b).  After sonication, 
essentially all cells with intracellular Ca2+ (> 99%) also exhibit calcein uptake 
(Figure 6b, upper-right quadrant).  This supports the idea that the large increase 
in intracellular Ca2+ is a result of the same plasma membrane wounds that lead 
to calcein uptake.  Furthermore, the level of intracellular Ca2+ corresponds well 
with the level of calcein uptake, and there is a high density region of cells at the 
highest Ca2+ loading (similar to the cells found to be annexin-positive in Figure 
5d) corresponding to the highest calcein uptake (Figure 6b, arrow).  For cells 
exposed to 3.6 atm of ultrasound pressure, approximately 7% of viable (PI-
negative) cells can be grouped into this high density region, and for cells 
exposed to 5.3 atm of ultrasound pressure, approximately 12% of viable (PI-
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negative) cells can be grouped into in this high density region.  These 
percentages closely mirror the number of cells found to be apoptotic from the 
annexin results shown above. 
 
Figure 6.  Intracellular Ca2+ versus calcein uptake.  (a) Non-sonicated samples 
have background levels of intracellular Ca2+ and calcein fluorescence.  (b) 
Sonicated cells show increased intracellular Ca2+ and calcein uptake.  A high 
density population exists at the highest levels of both molecules (arrow). 
 
Previous studies have indicated that the amount of cellular loading (i.e. the 
number of molecules per cell) caused by ultrasound varies within a sonicated 
sample (Cochran and Prausnitz 2001; Guzman, Nguyen et al. 2001; Keyhani, 
Guzman et al. 2001).  The level of intracellular calcein fluorescence, an indicator 
of the number of molecules transported across the plasma membrane, 
corresponds to the wound size and the amount of time a cell was open to 
external molecules (i.e. the extent of plasma membrane wounding) (Zarnitsyn, 
Rostad et al. 2007).  Therefore, cells with greater amounts of calcein uptake 
should also exhibit higher levels of intracellular Ca2+ since both molecules are 
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moving into the cell due to a concentration gradient between the cytosol and 
extracellular environment.  If ultrasound-induced apoptosis is the result of an 
intracellular Ca2+ switch, there should be a threshold level of cellular wounding—
as measured by calcein uptake—that leads to programmed cell death from an 
extracellular Ca2+ influx. 
To study effects of the level of wounding on intracellular Ca2+ 
concentrations and ultrasound-induced apoptosis, we divided calcein uptake 
cells into two subpopulations—high uptake and low uptake (shown in Figure 2c-
d).  High uptake cells were chosen as those previously described as having 
“equilibrium loading” of calcein (Guzman, Nguyen et al. 2002); whereas, the low 
uptake population includes all cells with sub-equilibrium calcein loading.  We then 
monitored these two populations over the course of 6 hours.  The overall 
percentage of low uptake cells (Figure 7a) remains constant over time (ANOVA p 
> 0.05); whereas, the percentage of high uptake cells (Figure 7b) decreases over 




Figure 7.  Uptake subpopulations over time.  Squares represent samples 
exposed to 3.6 atm of ultrasound pressure, and triangles represent samples 
exposed to 5.3 atm ultrasound pressure.  (a) The percentage of intact cells with 
low levels of calcein fluorescence does not change over the course of 6 hours.  
(b)  However, at 5.3 atm high uptake cells show a quantifiable percentage 
decrease after 6 hours (ANOVA p <0.05). 
 
The observed percentage decrease of high uptake cells along with the increased 
concentration of intracellular Ca2+ in these cells suggests that these cells are 
annexin-positive apoptotic cells, as discussed previously.  This relative 
correlation between apoptosis and uptake using Ca2+ as a link is necessary given 
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the limits of our flow cytometer and the fluorescent molecules available for the 
assays described above.  Unfortunately, we were not able to make the 
connection directly; however, we feel that the data given strongly support this 
association. 
5.4 Prevention of Apoptosis 
 Previous studies attempted to prevent apoptosis by chelating intracellular 
Ca2+ with BAPTA, AM, a Ca2+-specific chelator for live cells, during sonication 
(Honda, Kondo et al. 2004).  While this treatment was shown to prevent 
apoptosis, more cells died by necrosis (Population 3-type death) after sonication.  
The reason for the shift of cells from programmed cell death into uncontrolled 
modes of death can be explained by results found by Schlicher et. al. (Schlicher, 
Radhakrishna et al. 2006) and elsewhere in cellular wounding literature 
(Terasaki, Miyake et al. 1997; McNeil and Kirchhausen 2005).  In these studies, 
Ca2+ was shown to be an important signaling molecule in cellular wound repair.  
In the absence of Ca2+, cells cannot recruit lipid repair vesicles to the sites of 
plasma membrane disruption.  Consequently, chelating Ca2+ in cells prior to or 
during sonication inhibits the ability of cells to recover normal membrane function 
after ultrasound exposure, and thus renders the cell non-viable.  Other studies 
have indicated that Ca2+-initiation of cellular wound repair occurs very rapidly; 
whereas, commencement of apoptosis may take up to minutes (Berridge, 
Bootman et al. 1998).  These results indicate an opportunity to allow cells to 




Therefore, to save cells from apoptosis we added BAPTA, AM 1 min after 
sonication.  Within 2 hours after chelation, Ca2+ levels were reduced in all cells 
as shown in Figure 8a.  Furthermore, the number of apoptotic cells is decreased 
by approximately 50% at both ultrasound pressures 6 hours after sonication 
(Figure 8b).  By chelating the intracellular Ca2+ after sonication, we believe that 
wound-repair mechanisms were initiated, and therefore, uptake (Figure 8c) and 
short-term cellular viability (Figure 8d) were not affected by the BAPTA, AM 
treatment but apoptosis was still often averted.  This indicates that Population 2 




Figure 8.  The effects of Ca2+ chelation with BAPTA, AM.  For the bar graphs, 
the black bars represent samples without BAPTA, AM and the white bars 
represent samples with BAPTA, AM.  (a) BAPTA, AM chelates Ca2+ in all cells.  
The black line shows cells without BAPTA, AM and the gray line shows cells with 
BAPTA, AM.  (b) Apoptosis is decrease by 50% of intact cells following 
intracellular Ca2+ chelation.  (c)  The percentage of uptake cells remain 
unchanged after post-sonication Ca2+ chelation.  (d) Rapid viability losses are not 
changed after post-sonication Ca2+ chelation. 
5.5 Significance 
 These results show that Ca2+ is a key mediator of ultrasound-induced 
apoptosis.  We were able to use flow cytometry to connect the increase 
intracellular Ca2+ to an influx of external molecules following plasma membrane 
wounding.  Since Ca2+ is required to initiate plasma membrane repair, we added 
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BAPTA, AM, an intracellular Ca2+ chelator, after sonication, allowing time for 
activation of wound repair pathways.  We have shown that this chelation method 










6.1 Identification of Cellular Outcomes  
We have shown that there are three primary cellular outcomes 
immediately after sonication:  1) cells are unaffected by ultrasound; 2) cells are 
opened temporarily to allow for intracellular transport and then subsequently 
resealed; 3) cells are rendered non-viable by ultrasound.  Using flow cytometry, 
we correlated these scenarios to characteristic cellular populations.  For 
application purposes, maximizing the number of viable cells with intracellular 
uptake (Population 2) and minimizing the number of non-viable cells (Population 
3) is desirable.   
By monitoring these populations over the course of 6 h, we noticed that a 
subset of Population 2 cells, corresponding to those cells with the highest levels 
of intracellular uptake, were lost.  Since the proposed purpose of this research is 
to use ultrasound as a drug delivery method, the conclusion that ultrasonically-
induced delivery of external molecules causes a loss of cellular viability within 6 h 
post-sonication is counter to the goal of using ultrasound as a clinical tool.  
Therefore, we wanted to understand why these cells became apoptotic so that 
we could try to intervene.  Insight from previous studies led us to monitor levels 
of intracellular Ca2+ as a possible mediator of apoptosis.  Our Ca2+ assays 
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revealed that the intracellular Ca2+ concentrations in sonicated cells were 
increased beyond the normal levels present in cytosolic homeostasis and 
intracellular stores.  In this way, we found that intracellular Ca2+ levels correlated 
with intracellular levels of our model drug, calcein indicating that these cells were 
reversibly permeabilized by the ultrasonically induced cavitation.  This suggested 
that the desired effect of drug uptake was directly tied to the undesired effect of 
Ca2+ uptake that caused apoptosis. 
Previous studies have identified a heterogeneity in the levels of uptake in 
sonicated cells (Guzman, Nguyen et al. 2001; Keyhani, Guzman et al. 2001).  
Therefore, we wanted to look more closely at the relationship between the levels 
of calcein uptake and ultrasound-induced apoptosis.  The fact that some uptake 
cells are able to remain viable throughout the timeframe studied suggested that a 
threshold intracellular Ca2+ concentration could be responsible for the observed 
apoptosis, and that this concentration is strongly dependent upon the size of the 
ultrasound-mediated wounds in the plasma membranes of the cells.   
These results also explain the difference in apoptotic cell death at the two 
sonication pressures studied.  Samples exposed to ultrasound at 5.3 atm have a 
significantly higher portion of uptake cells (22% of intact cells) in the high uptake 
range than samples exposed to ultrasound at 3.6 atm (11% of intact cells), and 
as a result, a significantly higher portion of cells exposed to the higher sonication 
pressure undergo apoptosis than cells exposed to the lower sonication pressure.  
The increased number of permeabilized cells led to more cells with a Ca2+ 
concentration above the apoptotic threshold.  However, since the amount 
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delivered to cells is less at lower ultrasound pressures, it is often desirable to use 
higher pressure conditions.  Our work showed, however, that this approach to 
increase uptake can be counter productive, due to the associated increase in 
apoptosis. 
6.2 Ca2+ Chelation Prevents Apoptosis 
 Many apoptotic inhibition techniques may be effective in preventing 
ultrasound-induced apoptosis.  Apoptotic signaling pathways can be very 
complex, involving the activation and regulation of many different enzymes in 
parallel.  Therefore, it is often desirable to inhibit apoptosis by targeting the point 
of apoptotic initiation, thereby avoiding the intricate pathways.  For the purposes 
of these studies, Ca2+ chelation was chosen due to the belief that the influx of the 
Ca2+ ions into the cells was an initial apoptotic trigger.  However, since the repair 
of cellular membranes has also been shown to be mediated by Ca2+ signaling, 
we had to take into account the relative biochemical dynamics of apoptotic and 
plasma membrane repair. 
The sensitivity of Ca2+-mediated biochemical signaling is dependent on 
both the concentration of the Ca2+ as well as the amount of time an increased 
level of Ca2+ exists in the cell (Berridge, Bootman et al. 1998).  By understanding 
the concentration and temporal limits for intracellular Ca2+ in both cellular wound 
repair and programmed cell death, we can significantly alter cellular outcomes.  
While previous studies (Honda, Kondo et al. 2004) correctly identified Ca2+ as an 
important mediator of ultrasound-induced apoptosis, Ca2+ chelation during 
sonication resulted in uncontrolled viability loss.  An increase in intracellular Ca2+ 
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is needed to initiate plasma membrane wound repair (Terasaki, Miyake et al. 
1997; McNeil and Kirchhausen 2005); however, by chelating the Ca2+ with 
BAPTA, AM 1 min post-sonication, wound-repair pathways are able to proceed, 
but apoptotic signaling pathways are alleviated.  This allowed us to reduce the 
number of apoptotic cells without forcing cells into uncontrolled, necrotic death.  
The reduced levels of apoptosis after the Ca2+ chelation treatment also 
strengthen the hypothesis that an influx of external Ca2+ leads to apoptosis after 
ultrasound exposure. 
6.3 Modeling Gives Insight Into Wound Severity 
We have connected ultrasound-induced apoptosis to a large Ca2+ influx 
resulting from plasma membrane breaches that also lead to equilibrium loading 
of model drug molecules, such as calcein.  This connection allows us to use a 
molecular flux model developed by Zarnitsyn et. al. (Zarnitsyn, Rostad et al. 
2007) to approximate the minimum level of plasma membrane wounding that 
leads to sufficient Ca2+ influx to cause apoptosis.  This model was created to 
capture the dynamics of plasma membrane wound repair after sonication and in 
this way, predicts plasma membrane wound size as a function of intracellular 
uptake of calcein.  By integrating the flux equation to time at infinity (after the 
plasma membrane is completely repaired), the following relationship is obtained: 
,    ( 1) 
where Q is the total amount of calcein in a cell, Co is the initial concentration of 
calcein outside of the cell, Ro is the initial radius of the plasma membrane wound, 
trel is the characteristic relaxation time of the system, and K is a relationship of 
calcein diffusivities in cellular cytosol (Dα,cyt) and water (Dα) given below. 
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    ( 2) 
The total amount of calcein inside cells (molecules per cell) was found using 
methods described in Chapter 3.  The external calcein concentration was known, 
and the relaxation time and diffusivities were assumed to be constant and used 
as noted by Zarnitsyn.  Therefore, the initial radius of the ultrasound-induced 
plasma membrane wound can be found from Equation 1.  Although this is a first 
order model of plasma membrane wounding, it offers useful insight into the 
relative wound severity leading to specific bioeffects. 
 Zarnitsyn found that cells were no longer able to repair plasma membrane 
wounds with radii above 300 nm (Zarnitsyn, Rostad et al. 2007).  This means that 
the first wave of ultrasound-induced viability loss occurs during, or shortly after, 
sonication when wounds are greater than 300 nm.  Desirable wounds that lead to 
calcein uptake are repaired within 10 min after sonication has ended (Schlicher, 
Radhakrishna et al. 2006).  However, as we have shown, at a certain uptake 
threshold, cells will become apoptotic hours after sonication.  The radius leading 
to this amount of uptake was calculated using Equation 1 where Q was found by 
quantifying the number of molecules per cell in the high uptake population 
(established in Figure 2).  According to the model, short-term uptake can occur 
through cellular membrane wounds with radii up to 300 nm; however, after 
approximately 4 hours post-sonication, cells with wounds that initially had radii 
larger than 90 nm begin to die by apoptosis.  For cells to retain uptake molecules 
for the duration of this study, the initial wound radii had to be less than 90 nm. 
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 Figure 9 shows a schematic of the possible cellular outcomes post-
sonication.  The vertical axis indicates the relative severity of ultrasound-derived 
cellular wounds that lead to the various outcomes.  The values shown are 
derived from the model discussed above.  The horizontal axis indicates the 
timeline of cellular bioeffects occurring from sonication.  These values are based 
upon experimental observations.  From this diagram, we can establish windows 
within which ultrasound can be an effective drug delivery device.     
 
Figure 9.  Schematic showing cellular outcomes as a function of time after 
sonication and plasma membrane wound radius. 
6.4 Treatment Strategies 
 By chelating intracellular Ca2+ after sonication, we have shown the ability 
to save cells that would originally have died hours after ultrasound exposure.  
Since more cells are now able to maintain viability after ultrasound, we have 
effectively increased the “size” of allowable plasma membrane disruptions as 
discussed in the model above.  This is especially beneficial in therapeutics 
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requiring the delivery of large molecules such as DNA, RNA, and proteins.  For 
example, this treatment has the potential to significantly increase transfection 
efficiencies for ultrasound gene delivery because more cells would survive the 
large wounds needed to deliver DNA into the cytosol.  Clinically, this type of 
treatment could be realized by injecting a drug or therapeutic molecule into a 
patient, sonicating at the target site, and then adding an intracellular Ca2+ 










 Ultrasound has potential as a non-invasive drug delivery device; however, 
its clinical application has been hampered by a lack of predictability and 
controllability.  The first objective of this study was to characterize and quantify 
ultrasound-mediated bioeffects.  We have shown that the heterogeneous effects 
of ultrasound can be quantified by flow cytometric analytical methods.  Our 
analysis provides key insight into the relative importance of rapid cell death 
events by grouping cells into characteristic populations.  We then monitored the 
shift in these populations at two sonication pressures to gain a better 
understanding of the role of ultrasound in causing different types of rapid cell 
death.   We found that an increase in pressure causes more severe death effects 
(i.e. cellular lysis) but that at both pressures considered the majority of rapid 
death was resulted in a necrotic death mode creating cellular structures 
previously termed wound-derived perikarya.  Identifying these death modes could 
shed light on future methods to control ultrasound-induced rapid viability losses. 
 Secondly, we were also interested in understanding the long-term effects 
of ultrasound to cells initially characterized as viable after sonication.  Consistent 
with previous observations, we found that a significant portion of cells exhibited 
signs of programmed cell death 6 h after sonication; however, we were able to 
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connect this cell death to a loss of cellular homeostasis resulting from an influx of 
extracellular Ca2+ through the same large plasma membrane disruptions that 
cause high levels of intracellular uptake.  This connection led us to our last 
objective of controlling the downstream effects of ultrasound. 
 By identifying Ca2+ as a key apoptotic mediator, we hypothesized that 
intracellular Ca2+ chelation could allow us to prevent apoptosis.  However, since 
Ca2+ is an important signaling molecule in cellular wound repair and apoptosis, 
saving apoptotic cells by Ca2+ chelation had to be done after sonication.  The 
initial rush of Ca2+ ions into wounded cells allowed the activation of plasma 
membrane repair pathways to occur, but by removing the Ca2+ shortly after the 
end of sonication, we were able to prevent the onset of apoptosis.  Therefore, we 
increased the overall viability of sonicated samples up to 6 h after sonication. 
 Our findings offer promise toward the eventual control of ultrasound-
mediated bioeffects.  We have shown that short-term viability losses can be 
grouped into characteristic populations and are a function of ultrasound pressure.  
We have also demonstrated that long-term viability losses may be prevented by 
early intervention strategies to help the cells cope with the effects of plasma 
membrane wounding.  These conclusions suggest that all ultrasound-induced 
viability losses are a function of the initial wound to the cellular membranes.  
Therefore, the key to controlling the bioeffects caused by ultrasound may lie in 










 The findings of this work lead to a host of interesting studies that could 
help further the ultimate goal of using ultrasound as a drug delivery device.  The 
observation that post-sonication Ca2+ chelation can prevent ultrasound-induced 
apoptosis is extremely important, and therefore, more work should be done 
optimizing this technique.  Optimization parameters include the concentration of 
the chelator and the post-sonication time of chelation.  Through this optimization, 
valuable biochemical information can also be obtained.  For example, since one 
molecule of BAPTA, AM is responsible for sequestering one Ca2+ ion, the 
relationship between chelator concentration and apoptosis prevention also gives 
insight into the critical Ca2+ concentrations that lead to programmed cell death.  
This information could also be used to validate the Zarnitsyn model presented in 
Chapter 6.  A known concentration of intracellular Ca2+ can be connected to a 
Ca2+ flux into the cells—similar to the flux of calcein into the cell used for the 
model.  Also, by understanding the effects of Ca2+ chelation and various times 
after sonication, we can begin to elucidate the kinetics of the activation of wound 
repair and apoptotic pathways.  These techniques and results would be valuable 
not only to ultrasound research, but to any broad areas of research concerned 
with the affects of cellular wounding. 
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 Along with studies into Ca2+-mediated apoptosis, we should also be 
concerned with the effects of other molecules entering and leaving the cells 
during plasma membrane disruption.  Ca2+ is an important signaling molecule, 
but there are many other extracellular molecules that can also impact cellular 
behavior when plasma membrane function is lost.  Loss of cellular homeostasis 
could continue to affect cells after sonication and could contribute to a significant 
portion of the apoptosis that we have not been able to prevent through our 
chelation techniques. 
 While this study has the potential to solve the long-term viability problem, 
a majority of cell death is due to rapid losses of viability.  As we have shown, 
rapid death populations can be partially controlled by changing the ultrasound 
conditions—namely, ultrasound peak pressure and exposure time.  More 
rigorous studies should be done to understand the types of wounds that lead to 
short-term viability losses.  Ideally, we want to shift all cells into the viable uptake 
population (Population 2).  To do this, we need a better understanding of the 
physical mechanism of ultrasound that leads to the desired cellular effects.  One 
method of doing this would be to use a microdevice in which the location of 
cavitation can be varied relative to cells.  Using developed cavitation models, we 
could then gain insight into the interplay between cavitational forces and cellular 
responses that lead to the various populations described in this study.  This could 




 Recent studies in our lab have found that exposure to infrared lasers can 
also deliver molecules into cells without the rapid viability losses observed in 
ultrasound (Chakravarty 2007).  Since the amount of molecules delivered to cells 
is similar to the quantities observed using ultrasound, this treatment would 
probably cause long-term viability losses as described in Chapter 5.  Therefore, 
we could combine our treatment with the laser therapy to create a treatment with 
minimal viability losses and high uptake.  We may also be able to incorporate 
lessons learned from mechanistic studies on the function of laser-mediated drug 
delivery into our ultrasound delivery system. 
 Once we have optimized our system, an important step would be to 
demonstrate the effectiveness of the treatment in an animal model.  It is 
necessary to show that the lessons learned on cells in vitro can be extended into 
living tissues.  The ultimate goal of this research is to develop a delivery device 
that could be used in a clinical setting.  Achievement of this goal could be 
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